These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30888651)

  • 1. Ageing and Cognition.
    Juan SMA; Adlard PA
    Subcell Biochem; 2019; 91():107-122. PubMed ID: 30888651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plurality of patterns of cognitive impairment in normal aging and in dementia].
    Joanette Y; Belleville S; Gely-Nargeot M; Ska B; Valdois S
    Rev Neurol (Paris); 2000 Sep; 156(8-9):759-66. PubMed ID: 10992120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ageing-brain cognitive diseases: advances and promises.
    Demonet JF
    Curr Opin Neurol; 2017 Dec; 30(6):587-588. PubMed ID: 29028644
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.
    Hampel H
    J Alzheimers Dis; 2013; 33 Suppl 1():S79-86. PubMed ID: 22531423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive decline in normal ageing and early Alzheimer's disease: a continuous or discontinuous transition?
    Spaan PE; Dolan CV
    Behav Neurol; 2010; 23(4):203-6. PubMed ID: 21422555
    [No Abstract]   [Full Text] [Related]  

  • 6. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment.
    Lindeboom J; Weinstein H
    Eur J Pharmacol; 2004 Apr; 490(1-3):83-6. PubMed ID: 15094075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly.
    Driscoll I; Resnick SM; Troncoso JC; An Y; O'Brien R; Zonderman AB
    Ann Neurol; 2006 Dec; 60(6):688-95. PubMed ID: 17192929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventional programmes to improve cognition during healthy and pathological ageing: Cortical modulations and evidence for brain plasticity.
    Cespón J; Miniussi C; Pellicciari MC
    Ageing Res Rev; 2018 May; 43():81-98. PubMed ID: 29522820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.
    Daulatzai MA
    Neurotox Res; 2016 Oct; 30(3):295-337. PubMed ID: 27339162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of normal and pathological aging on cognition].
    Collette F; Salmon E
    Rev Med Liege; 2014; 69(5-6):265-9. PubMed ID: 25065230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Age-related cognitive decline: evaluation and prevention strategy].
    Capurso A; Panza F; Solfrizzi V; Torres F; Capurso C; Mastroianni F; Del Parigi A
    Recenti Prog Med; 2000 Mar; 91(3):127-34. PubMed ID: 10763344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
    Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of tau protein, beta-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages.
    Kapaki E; Liappas I; Paraskevas GP; Theotoka I; Rabavilas A
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):722-9. PubMed ID: 16035118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive reserve and the neurobiology of cognitive aging.
    Whalley LJ; Deary IJ; Appleton CL; Starr JM
    Ageing Res Rev; 2004 Nov; 3(4):369-82. PubMed ID: 15541707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional quantification of white matter hyperintensity in normal aging, mild cognitive impairment, and Alzheimer's disease.
    Chen YF; Wang H; Chu Y; Huang YC; Su MY
    Dement Geriatr Cogn Disord; 2006; 22(2):177-84. PubMed ID: 16912479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebral imaging in healthy aging: contrast with Alzheimer disease].
    Desgranges B; Kalpouzos G; Eustache F
    Rev Neurol (Paris); 2008 May; 164 Suppl 3():S102-7. PubMed ID: 18675034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NEIL Memory Research Unit: psychosocial, biological, physiological and lifestyle factors associated with healthy ageing: study protocol.
    Hannigan C; Coen RF; Lawlor BA; Robertson IH; Brennan S
    BMC Psychol; 2015; 3(1):20. PubMed ID: 26131366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.